The placement has been absorbed and the stock is as tightly held as its ever been imo.
We are now not far away from ethics approval. On the 11th August Argenica announced 4 to 6 weeks for approval. We are now 2 weeks in.
Argenica may finally give us a surprise to the upside and approval obtained earlier than later.
- Forums
- ASX - By Stock
- AGN
- Ann: Ethics Application Submitted for Phase 1 Trial
Ann: Ethics Application Submitted for Phase 1 Trial, page-5
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
77.0¢ |
Change
-0.005(0.65%) |
Mkt cap ! $98.63M |
Open | High | Low | Value | Volume |
77.5¢ | 80.0¢ | 77.0¢ | $149.1K | 190.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2820 | 77.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
77.5¢ | 2824 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2820 | 0.770 |
1 | 1307 | 0.765 |
2 | 13128 | 0.760 |
2 | 13755 | 0.755 |
4 | 24183 | 0.750 |
Price($) | Vol. | No. |
---|---|---|
0.775 | 2824 | 1 |
0.790 | 7800 | 1 |
0.800 | 46089 | 1 |
0.830 | 10000 | 1 |
0.840 | 9000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online